%0 Journal Article %A BINDEE KURIYA %A YE SUN %A GILLES BOIRE %A BOULOS HARAOUI %A CAROL HITCHON %A JANET E. POPE %A JOHN C. THORNE %A EDWARD C. KEYSTONE %A VIVIAN P. BYKERK %T Remission in Early Rheumatoid Arthritis — A Comparison of New ACR/EULAR Remission Criteria to Established Criteria %D 2012 %R 10.3899/jrheum.111341 %J The Journal of Rheumatology %P 1155-1158 %V 39 %N 6 %X Objective. To describe the frequency of remission in an early rheumatoid arthritis (ERA) cohort. Methods. The frequency of remission was evaluated, based on 8 definitions including the Boolean-based American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) criteria. Results. Of 369 patients, remission at 12 months ranged from 18% according to the ACR/EULAR clinical trial criteria to 40% according to the 28-joint Disease Activity Score (DAS28) < 2.6. Higher tender joint count, swollen joint count, and physician global scores were seen for DAS28-based definitions, and patient global assessment (PtGA) scores were almost 5-fold higher for DAS28 remission. Conclusion. Remission is achievable in ERA but its frequency differs according to the remission definition applied. Adoption of the new ACR/EULAR definition will limit the number classified as in remission, especially if the PtGA criteria are rated high for reasons other than inflammatory arthritis. %U https://www.jrheum.org/content/jrheum/39/6/1155.full.pdf